Lyme disease is a tick-borne multisystemic disease caused by Borrelia burgdorferi. Administering antibiotics is the primary treatment for this disease; however, relapse often occurs when antibiotic treatment is discontinued. The reason for relapse remains unknown, but recent studies suggested the possibilities of the presence of antibiotic resistant Borrelia persister cells and biofilms.
Introduction
Lyme disease is a leading tick-borne multisystemic disease caused by the spirochete Borrelia burgdorferi. The bacterium is transmitted by Ixodes ticks, which could feed on white-footed mice, rodents, deer, and birds [1, 2] . In the United States, there are approximately 300,000 people diagnosed with Lyme disease each year [3] . The frontline treatment for Lyme disease is antibiotics such as doxycycline for adults and amoxicillin for children [4] [5] [6] [7] [8] . These antibiotics are found effective in most cases of patients diagnosed with Lyme disease [5] [6] [7] [8] . However, according to the Centers for Disease Control (CDC), approximately 10-20% of the Lyme disease patients treated with anti biotics for a recommended 2 to 4 weeks experienced symptoms of fatigue, pain or joint and muscle aches [9] . In some patients, the symptoms even lasted for more than 6 months [9] . This condition was termed as "post-treatment Lyme disease syndrome (PTLDS)" or "chronic Lyme disease" [9] .
The mechanism associated with this condition in patients remains unclear. Though not proven, there are a couple of suggested explanations, such as the inability of the immune system to completely clear B. burgdorferi persisters [10] , or due to the presence of antigenic debris, which might cause immunological responses [11] . Another possibility of Borrelia evading the host immune clearance after antibiotic treatment is not well understood [12, 13] .
Previous in vivo studies on mice, dogs, and nonhuman primates have shown that B. burgdorferi could not be fully eliminated by various antibiotics such as doxycycline, ceftriaxone, and tigecycline. Also, a recent study had demonstrated the presence of Borrelia DNA in mice following 12 months of antibiotic treatment [14] . However, the culturing of viable organisms in Borrelia growth media could not be achieved in these studies [14] [15] [16] [17] . A recent study reported the presence of Borrelia DNA from a patient with PTLDS after antibiotic treatment [18] . Prospective clinical studies demonstrated no signifi cant effective antibiotic therapy and failed to show evidence of the continued presence of B. burgdorferi in patients with long-term symptoms [19, 20] . Other trials using prolonged intravenous ceftriaxone treatment only improved fatigue symptoms [21] . In summary, fi ndings suggest that conventional treatments may not completely eliminate Borrelia persisters.
The life style of B. burgdorferi is complex as it exists in different morphological forms like the spirochetes, spheroplast (or L-form), round bodies, and biofi lms [7, 13, [22] [23] [24] [25] . Several studies show that Borrelia can change into round bodies when conditions become unfavorable such as changes in temperature, high or low pH, starvation, antibiotic exposure, and/or even an attack from the immune system [7, [23] [24] [25] . Borrelia in these defensive forms becomes dormant, immobile, and remains in this morphological state until it fi nds favorable conditions to return to its spirochete form [7, 22, 24, 26] . The most effective hiding place proposed for B. burgdorferi is the recently suggested biofi lm form [24] . Bacterial biofi lms are organized communities of cells enclosed in a self-produced hydrated polymeric matrix or extracellular polymeric substances (EPS), which is a complex mixture of polysaccharides, lipids proteins, nucleic acids, and other macromolecules [24, 27] . This unique matrix protects the underlying cells from antimicrobial agents [24, 27] . Elimination of pathogenic bacteria in their biofi lm form is very challenging since these sessile bacterial cells can endure the host immune responses and are much less susceptible to antibiotics or any other biocides than their individual planktonic counterparts [24, 27] . Biofi lm resistance is based upon multiple mechanisms, such as phenotypic changes of cells forming in the biofi lm, the expression of effl ux pumps, and the presence of persister cells, which resist killing when exposed to antimicrobial agents [28, 29] .
Recently, we provided evidence that B. burgdorferi is capable of forming biofi lms in vitro [24] . The aggregation of spirochete and round body forms with several different protective layers which makes up the biofi lm and extracellular polymeric substances (EPS) is proposed to be a signifi cant factor in antibiotic resistance [24] . It is also reported that the biofi lms have higher population of the persister cells, which could lead to the antimicrobial resistance portrayed by these forms [24, 29] .
Our previously published results on the in vitro effects of doxycycline on B. burgdorferi showed that different morphological forms have unique sensitivities to antimicrobial agents [7] . A recent study by J. Feng et al. showed that doxycycline was effective in reducing the spirochetes but not the persisters of B. burgdorferi [30, 31] . Studies have also showed that doxycycline and amoxicillin could eliminate the spirochetal form of B. burgdorferi, but the dormant persisters/biofi lm-like aggregates/microcolonies were not susceptible to these antibiotics [7, 31] . Therefore, there is an urgent need to fi nd effective agents, which can target/eliminate all the morphological forms of Borrelia.
Natural antimicrobial agents, which have been used for thousands of years, have been shown to be effective against various pathogens [32] . Many in vitro and clinical studies have demonstrated their effectiveness not only against B. burgdorferi but also against many other pathogens [33] [34] [35] [36] [37] [38] . Stevia rebaudiana which belongs to the Asteraceae family is typically referred to as honey leaf or sweet leaf, and due to its natural sweetness, it is used as a natural substitute to synthetic sweetener [39] [40] [41] . The leaf extract of Stevia possesses many phytochemicals, which include austroinullin, β-carotene, dulcoside, nilacin, rebaudi oxides, ribofl avin, steviol, stevioside, and tiamin with known antimicrobial properties against many pathogens [40, 42, 43] . The role of these compounds is mainly to protect the plant from microbial infection and adverse environmental conditions [38] [39] [40] [41] [42] [43] . Stevia is also well known in traditional medicine for its use in treatment of many diseases like diabetes, high blood pressure, and weight loss [44, 45] . In a few clinical studies, it is reported that the phytochemical stevioside reduces blood pressure in patients experiencing mild hypertension and reduces blood glucose levels in type 2 diabetic patients [44, 45] . It was also demonstrated that the patients did not encounter any adverse effects from the use of stevioside [44, 45] .
Considering the effectiveness of Stevia leaf extract in laboratory and clinical studies, we evaluated the antimicrobial potential of Stevia (whole leaf extracts) against the Lyme disease causing pathogen, B. burgdorferi, in a goal to eliminate all the different morphological forms in vitro. To effectively evaluate the whole Stevia leaf extract, we compared the antimicrobial effect of Stevia with antibiotics (doxycycline, cefoperazone, daptomycin) and their combination, which were recently found effective against Borrelia persisters.
Materials and methods

Bacterial culture conditions and media requirements
Low passage isolates (≤ 8) of B. burgdorferi strain B31 were obtained from the American Type Culture Collection (ATCC 35210) and were cultured in BarbourStoner-Kelly H (BSK-H) media (Sigma, St Louis, MO) supplemented with 6% rabbit serum (Pel-Freez ® , Rogers, AR). The antibiotic free cultures were maintained in sterile 15 ml glass tubes and incubated at 33 °C with 5% CO 2 . For logarithmic (log) phase, 1 × 10 5 cells/ml were seeded in glass tubes and allowed to grow for 5 days. The effectiveness of the antimicrobial agents on the logarithmic phase was tested by inoculating 1 × 10 5 spirochetes/ml from the fi ve-day grown culture (containing only spirochetes) in 90 μl of BSK-H media in 96-well tissue culture plates (BD Falcon, Franklin Lakes, NJ), which were incubated for 5 days at 33 °C with 5% CO 2 . The cells were treated with antimicrobial agents for 3 days after a twoday incubation period. Likewise, for the stationary phase, 1 × 10 5 cells/ml were seeded in glass tubes and allowed to grow for 7 days. The effectiveness of the antimicrobial agents was tested by inoculating 1× 10 6 spirochetes/ml in 90 μl of BSK-H media in a 96-well tissue culture plate, which was incubated for 8 days at 33 °C with 5% CO 2 . The persister cells in stationary phase were treated with antimicrobial agents for 3 days after 5 days of incubation. Biofi lms were generated by inoculating 5 × 10 6 cells/ml of Borrelia spirochetes in 1 ml of BSK-H media in fourwell chamber slides (Thermo Scientifi c, Waltham, MA) or plastic/collagen-coated tissue culture 48-well plates (BD Falcon), which were incubated for 7 days at 33 °C with 5% CO 2 . The treatment regime for the biofi lms was the same as that for the stationary phase. , and Truvia ® were purchased from health food stores in the USA and were labeled randomly as Stevia A, B, C, and D. The extracts A, B, and C were formulated by standard alcohol extraction method whereas extract D was purchased in a powder form dissolved in distilled water. Stevioside (Sigma) was prepared in 0.001% DMSO and further diluted in 1× phosphate buffered saline (PBS, 0.1 M, pH 7.4 from Sigma). The antibiotics doxycycline, cefoperazone, and daptomycin (Sigma) at a concentration of 10 μg/ml were prepared in PBS. All antimicrobial agents were sterilized using a 0.2-μm fi lter unit (EMD Millipore, Billerica, MA). The antibiotic solutions were aliquoted and stored at minus 20 °C.
Compounds and antibiotic preparation
Determining the protein concentrations of the antimicrobial agents
Since the concentration of the antimicrobial components in the Stevia extracts A, B, C, and D were unknown, the concentration units used initially involved the use of part of solute per 50 parts of solution (1:50 dilution). The protein content of antimicrobial agents was determined by Bradford assay (Sigma) using serial dilutions of 2 mg/ml of bovine serum albumin stock (Sigma) in PBS pH 7.4 as a standard. Bradford reagent was added to the antimicrobial agents according to the manufacturer's instructions and incubated for 10 min at room temperature with gentle shaking. The absorbance was measured at 595 nm using a BioTek spectrophotometer.
In vitro antimicrobial susceptibility testing of B. burgdorferi
The effective antibiotics and the antibiotic combination identifi ed [30] were tested to compare and evaluate the effectiveness of Stevia on B. burgdorferi. As a positive control, doxycycline (10 μg/ml) was used. As a negative control, 1× PBS at pH 7.4 was used to dissolve antibiotics and 25% alcohol (Fisher Scientifi c, Pittsburg, PA) was used since all the Stevia extract contained the same alcohol diluent.
SYBR Green I/PI assay
To evaluate live and dead cells, standard SYBR Green I/ propidium iodide assay (SYBR Green I/PI) was performed as previously described [30, 31, 46, 47] . To 1 ml of sterilized distilled water, 10 μl of SYBR Green I (10,000× stock, Invitrogen, Grand Island, NY) and 30 μl of propidium iodide (Thermo Scientifi c) were briefl y mixed. The staining mixture (10 μl) was added to all the wells containing B. burgdorferi and was incubated in the dark for 15 min. The plates were measured using a fl uorescent reader (BioTek FLx800) by setting the excitation wavelength at 485 nm and the absorbance wavelength at 535 nm (green emission) and 635 nm (red emission). The standard equation was determined from 1 × 10 6 cells (logarithmic phase), 5 × 10 6 cells (stationary phase), and 1 × 10 7 cells (7 days and 14 days subculture). A live and dead population was prepared. For the dead cell population, the cells were killed by adding 300 μl of 70% isopropyl alcohol (Fisher Scientifi c). B. burgdorferi suspensions at different ratios of live/dead cells (0:10, 2:8, 5:5, 8:2, 10:0) were added to the wells of the 96-well plate accordingly. The staining mixture was added to each of the fi ve samples, and the plate was read as above. Using least square fi tting analysis, the regression equation was calculated between the percentage of live bacteria and green/red fl uorescence ratios. The regression equation was used to calculate the percentage of live cells in each sample of the screening plate. Also, images of the treated sample were taken using fl uorescent microscopy (Leica DM2500).
Total viable counts of B. burgdorferi
As a confi rmation test, the SYBR Green/PI stained cultures were assessed for cell growth by directly counting live and dead bacteria using a bacterial counting chamber (Hausser Scientifi c, Horsham, PA) and fl uorescent microscopy (Leica DM2500). As above, using least square fi tting analysis, the regression equation was calculated between the percentage of live bacteria and green/red fl uorescence ratios. The regression equation was used to calculate the percentage of live cells in each sample.
Long-term subculture experiments to assess viability of treated B. burgdorferi stationary phase culture
To assess if the treated stationary phase cultures can regrow in fresh media, 96-well plates were fi lled with 100 μl of fresh BSK-H media. From the treated stationary phase cultures, 1:75 dilution of treated stationary phase culture was added to a sterile 96-well plate (BD Falcon) containing 100 μl of fresh BSK-H media and incubated for 7 days and 14 days without antimicrobial treatment. Following incubation, the viability was assessed using the SYBR Green I/PI assay and direct counting method.
Crystal violet biofilm assay
The effi cacy of the antimicrobial agents on biofi lms was determined by quantifying the total biomass using crystal violet staining. Following incubation, the media was slowly discarded leaving behind the attached biofi lms on the surface of the plate. The attached biofi lms were collected by adding 500 μl of PBS (0.1 M, pH 7.4) to the samples. All centrifugation steps were performed at 12,000 × g at room temperature. Biofi lms were pelleted for 5 min, and the supernatant was discarded. A volume of 50 μl (0.01%) crystal violet (Sigma) was added to the pellet, and the mixture was incubated for 15 min at room temperature. The unbound stain was removed by pelleting the biofi lms for 5 min and by discarding the supernatant. The pellet was washed with 200 μl PBS and again pelleted for 5 min. The supernatant was discarded in addition to adding 200 μl of 10% acetic acid (Sigma) to the pellet to release and dissolve the stain. The samples were then incubated at room temperature for 15 min. Biofi lms were pelleted for 5 min prior to extracting the crystal violet stain from the biofi lms, which were transferred to a 96-well plate, and absorbance was measured at 595 nm using a BioTek spectrophotometer.
Live/dead bacterial staining technique
To visualize the antimicrobial sensitivity of biofi lms, the treated biofi lms were stained using SYBR Green (Invitrogen) and propidium iodide (Thermo Scientifi c). The stains were prepared as per the SYBR Green I/PI assay protocol. To each well of the chamber slide, 5 μl of the staining mixture was added and allowed to incubate in the dark for 15 min. The media was removed carefully not to disturb the attached biofi lm. Slides were cover slipped, and images were taken using fl uorescent microscopy (Leica DM2500).
Atomic force microscopy
To visualize the morphology of the antimicrobial treated biofi lms grown on glass chamber slides (Thermo Scientifi c), the media was carefully removed without disturbing the biofi lm. Contact mode AFM imaging in air was performed on a Nanosurf Easyscan 2 AFM (Nanosurf) using SHOCONG probes (APPNANO). Images were processed using Gwyddion software (Nečas and Klapetek).
Statistical analysis
Statistical analysis was performed using two-tailed Student's t-test (Microsoft Excel, Redmond, WA) and graphed using GraphPad Prism ® 6.0 (La Jolla, CA). All experiments were performed a minimum of three separate times with at least three samples per experiment. Data was normalized to the control and presented as the mean ± SD.
Results
In this study, we compared and evaluated the antimicrobial effect of S. rebaudiana whole leaf extract along with the antibiotics doxycycline, cefoperazone, and daptomycin on the different morphological forms (spirochetes, round bodies, and biofi lms) of B. burgdorferi. We used a recently developed high throughput screening method [30, 31, 46] to assess the viability of the log phase and stationary phase B. burgdorferi after the different antimicrobial treatments (quantitatively and qualitatively) in conjunction with direct counting methods as described in our previous publication [7] . Similar to recent studies, we have evaluated both the log phase B. burgdorferi cultures which consist of individual spirochetes, the stationary phase cultures which consist of the persister cells, and the most resistant form of B. burgdorferi, the attached surface biofi lms. Finally, atomic force microscopy was used in conjunction with the aforementioned methods, to visualize changes in the morphology in attached biofi lms before and after antibiotic treatments.
Preliminary screening of different Stevia extracts
Here, we fi rst evaluated four different commercially obtained Stevia extracts (3 alcohol extracts and one extract in powder form) and the purifi ed Stevioside on B. burgdorferi to fi nd the most effective agent for further studies using the SYBR Green/PI assay. The protein concentration of the four Stevia leaf extracts was determined by a standard Bradford assay and ranged from 1.2 μg/ml to 1.9 μg/ ml. Stevioside was tested at concentration from 100 to 1000 μg/ml, concentration as suggested from a previous study [42] . For the prescreening experiments, we have pretested all agents on the log and stationary phase Borrelia cultures at different concentrations using the SYBR Green/ PI assay. Our results showed that Stevia A, Stevia B, and Stevia C alcohol extracted agents had signifi cant effects on the viability of Borrelia cells, but Stevia D, powdered form, and Stevioside did not show any signifi cant effect on both the log phase and the stationary phase cells. Figure 1 shows a representative experiment demonstrating that the alcohol extracted based Stevia agents (A, B, C) were the most effective against the Borrelia persisters, while the powder form of Stevia leaf extract (D) and Stevioside had no effect on those resistant cells. Furthermore, Stevia A showed the most promising effect in all experiments, and therefore, Stevia A was used in the subsequent experiments on the different morphological forms of B. burgdorferi. Fig. 2 . Susceptibility of log phase (5 days) and stationary phase (8 days) Borrelia burgdorferi to antimicrobial agents after a three-day treatment determined by (A) SYBR Green I/PI assay, (B) direct counting of live and dead cells stained using a mixture of SYBR Green I and propidium iodide using fluorescent microscopy. (C) Representative live/dead images of log and stationary phase B. burgdorferi to antimicrobial agents taken at 200× magnification (Scale bar − 100 μm). Doxycycline (DoxC) was used as a positive control. 1× PBS and 25% alcohol were used as negative controls, respectively. All antibiotics individually as well as in combination were used at a concentration of 10 μg/ml. Stevia A was used at a concentration of 1.2 μg/ml. n = 3 ± SD, * p ≤ 0.05, ** p ≤ 0.01 compared to the control. n = 3 ± SD, To compare and evaluate the effectiveness of Stevia on B. burgdorferi, recently identifi ed potential antibiotics and their combinations were tested along with Stevia A extract using the SYBR Green I/PI assay on both log and stationary phase cultures. Appropriate amounts of 1× PBS pH 7.4 and 25% alcohol were used as negative controls.
According to the SYBR Green I/PI assay and the live/ dead images, treatment with 1× PBS or 25% alcohol did not signifi cantly reduce the viability of the spirochete rich log phase culture and persisters rich stationary cultures compared to the control ( Fig. 2A, and 2C : panels i-iii and ix-xi). Figure 2C : panels i-iii and ix-xi demonstrated that the control B31 culture, 1× sterile PBS, and 25% alcohol treated cultures comprised only live cells (green).
In the next set of experiments, we tested several previously reported effective antibiotics on B. burgdorferi such as doxycycline, cefoperazone, and daptomycin individually and in combinations [30, 31] .
Doxycycline, as reported earlier [30, 31] was significantly able to reduce the viability of log phase B. burgdorferi by ~99% compared to the control ( Fig. 2A , and 2C: panel iv). However, doxycycline treatment had no signifi cant effect on the cells in the stationary phase cultures as observed by increasing proportion of viable cells after antibiotic exposure compared to the control ( Fig. 2A, and 
2C: panel xii).
Cefoperazone at 10 μg/ml, which was previously identifi ed as one of the drugs with high activity against Borrelia persisters [30, 31] , signifi cantly reduced the log phase viability of Borrelia by ~99% ( Fig. 2A, and 2C: panel v) but, in contrast, only reduced the stationary phase viability by ~18% compared to the control (Fig. 2A) . A large population of live round body forms and a mixture of live and dead spirochetal cells were observed in stationary phase culture (Fig. 2C: panel xiii) .
Daptomycin, one of the other drugs previously identifi ed with potent activity against Borrelia persisters [30, 31] , also signifi cantly reduced the live spirochetal enriched log phase culture by ~23%, but it was less sensitive in reducing viable cells in the stationary phase (~16% reduction of live cells) compared to the control (Fig. 2A) . Images demonstrated that cells treated with daptomycin, both log and stationary phase show more live cells than dead cells (Fig. 2C : panels vi and xiv) compared to control.
A recent study reported that the combination of doxycycline, cefoperazone, and daptomycin successfully eliminated both spirochetes and persisters [30] . Our data from this study also confi rmed the effectiveness of these threeantibiotic combination on B. burgdorferi by signifi cantly eliminating the live log phase spirochetes (100% effect) and also signifi cantly reduced the viability of the stationary phase culture by ~86% ( Fig. 2A, and 2C : panels vii and xv).
In these experiments, we also tested potential antimicrobial agent Stevia A as an individual agent and compared its effectiveness to the individual antibiotics and the three-antibiotic combination. In Fig. 2A , and 2C: panels viii and xvi, Stevia A signifi cantly eliminated the log phase spirochetes and the stationary phase persisters compared to the control (100% effect for both). The log phase and the stationary phase culture treated with Stevia A had only dead cells (Fig. 2C: panels viii and xvi) .
In Fig. 2A , the effectiveness of doxycycline and the three-antibiotic combination was compared with Stevia A. A signifi cant elimination (p value ≤ 0.01) in the persisters was found with Stevia A compared to doxycycline.
Direct counting confirms the effectiveness of Stevia A on the log phase spirochetes and stationary phase rich persisters
To further validate the effectiveness of the antimicrobial agents evaluated using the SYBR Green I/PI assay, direct counting was performed as described previously [7, 31] .
According to the direct counting method, the negative controls, 1× sterile PBS and 25% alcohol, did not signifi cantly reduce the number of viable cells in both the log phase and stationary phase compared to the control (Fig. 2B) . While doxycycline signifi cantly reduced the log phase viability of Borrelia by ~98%, it did not reduce the stationary phase viability compared to the control (Fig. 2B) . Cefoperazone was also signifi cantly able to reduce the viability of log phase Borrelia by ~99% (Fig. 2B) , whereas cefoperazone in the stationary phase cultures was less effective (~32% reduction) in eliminating the persisters as observed by increasing proportion of remaining viable cells after antibiotic exposure compared to the control (Fig. 2B, and 2C: panel xiii) . Daptomycin, signifi cantly reduced the live spirochetal enriched log phase culture by ~44% and also signifi cantly reduced the stationary phase by ~42% compared to the control (Fig. 2B) . The threeantibiotic combination of doxycycline, cefoperazone, and daptomycin signifi cantly eliminated the log phase culture and also the stationary phase culture by ~84% compared to the control (Fig. 2B) . The potent antimicrobial agent, Stevia A, signifi cantly eliminated the log phase spirochetes and signifi cantly reduced the persisters by ~94% (Fig. 2B) .
In Fig. 2B , the effectiveness of doxycycline and the three-antibiotic combinations was compared with Stevia A. A signifi cant reduction (p value ≤ 0.01) in the persisters was found with Stevia A compared to doxycycline.
Effectiveness of Stevia A after a 7-day and 14-day subculture of antimicrobial treated B. burgdorferi
In the above-mentioned experiments, we have demonstrated the effectiveness of Stevia A on both spirochetes and the persisters of Borrelia and provided data that its signifi cant effect is very comparable to the three-antibiotic combination reported previously [31] . To confi rm the effectiveness of Stevia on the persisters, we performed a 7-day and 14-day subculture experiment in fresh BSK-H medium to observe if the persisters, if any, still left in the culture, could regrow in fresh medium assayed by the SYBR green I/PI and the direct counting methods.
As expected, the treatment with negative controls, 1× PBS and 25% alcohol, was able to successfully repopulate the media with predominating green live cells similar to the untreated B31 control after a 7-and 14-day subculture ( Fig. 3A, and 3C : panels i-iii and ix-xi). The threeantibiotic combination and cefoperazone resulted in 5-7% of viable cells after a 7-day subculture, but there was a signifi cant 14% increase in the number of viable cells treated with cefoperazone and a 11% increase in viable cells treated with the three-antibiotic combination after a 14-day subculture (Fig. 3A, and 3C : panels v, vii, xiii, and xv). There was a signifi cant 13% and 53% increase in viable cells from the sample treated with doxycycline after a 7-day subculture and a 14-day subculture, respectively ( Fig. 3A, and 3C : panels iv and xii). The treatment with daptomycin, however, produced predominating live cells Fig. 3 . A 7-day and 14-day subculture of 8-day-old Borrelia burgdorferi stationary phase culture treated with antimicrobial agents determined by (A) SYBR Green I/PI assay and direct counting of live and dead cells stained using a mixture of SYBR Green I and propidium iodide using fluorescent microscopy. (B) Representative live/dead images of a 7-day-old subculture on stationary phase B. burgdorferi treated with antimicrobial agents taken at 200× magnification (Scale bar − 100 μm). Doxycycline (DoxC) was used as a positive control. 1× PBS and 25% alcohol were used as negative controls respectively. n = 3 ± SD, * p ≤ 0.05, ** p ≤ 0.01 compared to the control. n = 3 ± SD, + p ≤ 0.05, ++ p ≤ 0.01 (doxycycline compared to Stevia A). n = 3 ± SD, * p ≤ 0.05, ** p ≤ 0.01 (doxycycline compared to Stevia A). Abbreviations: doxycycline -DoxC, cefoperazone -CefP, daptomycin -DapM after a 7-day and 14-day subculture (Fig. 3A, and 3C : panels vi and xiv). Interestingly, there was no regrowth with the sample treated with Stevia A as there were only dead cells (100% elimination) after a 7-day subculture, and only a 10% increase in viable cells was observed after a subculture for 14 days (Fig. 3A, and 3C : panels viii and xvi).
In Fig. 3A , the effectiveness of doxycycline and the three-antibiotic combination after a 7-day and a 14-day subculture was compared with Stevia A. A signifi cant reduction (p value ≤ 0.05) in the regrowth of Borrelia was found with Stevia A compared to doxycycline after a 14-day subculture.
Direct microscopic counting confi rmed the SYBR Green I/PI assay and showed that drug-free controls and the negative controls (1× PBS and 25% alcohol) grew well in the 7-day and 14-day subcultures (Fig. 3B) . Samples treated with doxycycline, cefoperazone, and the three-antibiotic combination produced ~2% viable cells after 7 days (Fig. 3B) . Cefoperazone and the three-antibiotic combination produced ~1% viable cells after a 14-day subculture (Fig. 3B) . However, there was an increase in viable cells by 68% treated with doxycycline after a 14-day subculture (Fig. 3B ). Daptomycin treated cells were able to recover better than the other antibiotic counterparts with regrowth similar to the drug-free control in the 7-and 14-day subcultures (Fig. 3B ). Samples treated with Stevia A after a 7-day subculture showed no signs of regrowth, and only 1% of viable cells were observed after a 14-day subculture (Fig. 3B) .
In Fig. 3B , the effectiveness of doxycycline and the three-antibiotic combination in the direct counting method, after a 7-day and a 14-day subculture, was compared with Stevia A. Signifi cant reduction (p value ≤ 0.01) in the regrowth of Borrelia was found with Stevia A compared to doxycycline after a 14-day subculture.
Stevia A significantly reduced Borrelia biofilms grown on plastic and collagen surfaces
Multiple morphological forms of B. burgdorferi, i.e, spirochetal form, round bodies, and biofi lms have been observed to have different antimicrobial susceptibilities [7] . In our previous publication, we characterized the antibiotics sensitivity of the biofi lm form of B. burgdorferi and found that it is the most resistant form [7] . In this study, to evaluate the effect of antimicrobial agents on Borrelia biofi lms grown on plastic and collagen surfaces, we stained the antimicrobial treated biofi lms with crystal violet to quantify the effectiveness of the different antimicrobial agents.
Biofi lms grown on plastic surface and treated with negative controls, 1× PBS or 25% alcohol, did not show reduction in the biofi lm masses compared to the untreated biofi lm control (Fig. 4) . Biofi lms treated with doxycycline, cefoperazone, daptomycin, and the three-antibiotic combination showed signifi cant increase in Borrelia biofi lm mass compared to the drug-free control (Fig. 4) . The treatment with Stevia A, however, signifi cantly reduced Borrelia biofi lms on plastic by ~40% compared to the control (Fig. 4) .
Biofi lms grown on collagen-coated surface show that the treatment with negative control, 1× PBS or 25% alcohol, did not show reduction in the biofi lm masses compared to the control (Fig. 4) . Treatments with doxycycline and daptomycin did not have any signifi cant effect on Borrelia biofi lm mass (Fig. 4) . There was an increase in Borrelia biofi lms grown on collagen when treated with cefoperazone, and in contrast, there was a 10% reduction observed in these biofi lms when treated with the threeantibiotic combination compared to the control (Fig. 4) . In addition, biofi lms treated with Stevia A also showed signifi cant reduction on collagen by ~34% compared to the control (Fig. 4) . In order to assess the effectiveness of doxycycline and the three-antibiotic combination to Stevia A, the results in Fig. 4 showed that there was a signifi cant reduction in the total Borrelia biomass grown on plastic and collagen surfaces by Stevia A compared to doxycycline and the three-antibiotic combination (p value ≤ 0.01).
Stevia A decreases viability in attached Borrelia biofilms
In order to directly observe the viability of attached biofi lms after antimicrobial treatment, we stained the treated biofi lms using a mixture of SYBR Green I and propidium iodide (live/dead stains). The Borrelia biofi lms treated with 1× PBS and 25% alcohol were large and compact, mostly staining green, depicting that the biofi lm was live Fig. 4 . Susceptibility of Borrelia burgdorferi biofilms grown on plastic and collagen-coated surface to antimicrobial agents after a three-day treatment determined by crystal violet assay. Doxycycline (DoxC) was used as a positive control. 1× PBS and 25% alcohol were used as negative controls, respectively. All antibiotics individually as well as in combination were used at a concentration of 10 μg/ml. Stevia A was used at a concentration of 1.2 μg/ml. n = 3 ± SD, * p ≤ 0.05, ** p ≤ 0.01 compared to the control. n = 3 ± SD, Fig. 5 : panels ii and iii). The biofi lms treated with cefoperazone were signifi cantly smaller compared to the biofi lms treated with doxycycline, and both were green with small red spots indicating that they were alive (Fig. 5: panels iv and v). The biofi lms treated with daptomycin were large and compact and stained mostly green with live cells (Fig. 5: panel vi) , whereas the biofi lms treated with the antibiotic combination were made up with a mixture of live and dead cells with live cells predominating (Fig. 5:  panel vii) . Borrelia biofi lm treatment with Stevia A stained predominantly red, depicting that the biofi lm had mainly dead spirochetes and round bodies (Fig. 5: panel viii) . The   Fig. 5 . Representative live/dead images of Borrelia biofilms treated with different antimicrobial agents followed by staining with SYBR Green I and PI dye mixture taken at 200× magnification. Doxycycline (DoxC) was used as a positive control. 1× sterile PBS and 25% alcohol were used as negative controls, respectively. All antibiotics individually as well as in combination were used at a concentration of 10 μg/ml. Stevia A was used at a concentration of 1.2 μg/ml. Scale bar −100 μm. Abbreviations: doxycycline -DoxC, cefoperazone -CefP, daptomycin -DapM Fig. 6 . Representative atomic force microscopy images showing the ultrastructural details of Borrelia biofilm before and after treatment with antimicrobial agents. The preparations of B. burgdorferi strain B31 biofilms on chamber slides are described in Materials and methods section. All biofilms were scanned at 0.4 Hz using contact mode and the individual Z ranges (height) are indicated next to each panel by means of a scale. The images were scanned using the Nanosurf Easyscan 2 software, and the images were processed using Gwyddion software. All antibiotics individually as well as in combination were used at a concentration of 10 μg/ml. Stevia A was used at a concentration of 1.2 μg/ml. Abbreviations: doxycycline -DoxC, cefoperazone -CefP, Daptomycin -DapM morphology of the Stevia A treated biofi lm was small and loosely packed compared to the biofi lms treated with antibiotics ( Fig. 5: panel viii) .
AFM analysis shows loose morphology with biofilms treated with Stevia A
The atomic force microscopic images, which are 3D rendered and digitally colored for improved visualization, show the ultra structural features in the biofi lms before and after treatment with antimicrobial agents. The red color shows the highest peak in the biofi lms, which mainly indicates the potential presence of biofi lm EPS matrix. The drug-free control had a very compact and rigid structure with notable EPS buildup (Fig. 6: panel i) . The biofi lms treated with doxycycline, cefoperazone, daptomycin, and the three-antibiotic combination were similar to the control having compact structure with more potential layers of EPS (Fig. 6 : panels ii-v). Interestingly, Stevia treated biofi lms have a very loose structure with the EPS layer almost not formed ( Fig. 6: panel vi) .
Discussion
In this study, we evaluated the antimicrobial potential of whole leaf Stevia extracts against the Lyme disease causing pathogen, B. burgdorferi. We compared the antimicrobial effect of Stevia with antibiotics (doxycycline, cefoperazone, daptomycin) and their combination, which were recently found effective against Borrelia persisters [31] . For this study, we have chosen to utilize a novel quantitative method developed by J. Feng et al. combined with our previously reported direct counting method [7, 30, 31, 46] . Findings from this study show that Stevia whole leaf extract, as an individual agent, was effective against all known morphological forms of B. burgdorferi.
In the preliminary screening experiment using different extracts of Stevia, we demonstrated a signifi cant variation in the effectiveness of the alcohol extracts of Stevia (Stevia A, Stevia B, and Stevia C) on Borrelia persisters compared to the powder form of Stevia (Stevia D) and purifi ed Stevioside which did not show any effect (Fig. 1) . We also found that one of the Stevia compounds, Stevia A, signifi cantly eliminated Borrelia persisters compared to other Stevia extracts (Fig. 1) . This might be explained by the reported variations observed in the different phytochemical concentrations of different Stevia extracts, which resulted from the growing conditions and agricultural practices followed [47, 48] . Since Stevia A was effective in eliminating Borrelia persisters, Stevia A was chosen for further investigating the effectiveness on the different morphological forms of B. burgdorferi.
In the next set of experiments, we compared the effectiveness of Stevia A to the antibiotics and the threeantibiotic combinations found effective in recent reports by J. Feng et al., [31] fi rst to Borrelia spirochetes and then the persisters using the quantitative method developed by J. Feng et al. and E. Sapi et al. We observed that Stevia A, even at a lower concentration (1.2 μg/ml), could signifi cantly eliminate the viability of early log phase and stationary cultures of B. burgdorferi using the SYBR Green I/ PI method ( Fig. 2A, and 2C : panels viii and xvi) which was also confi rmed using the direct counting method (Fig. 2B, and 2C : panels viii and xvi). According to a report by J. Feng et al. (2015) , daptomycin and cefoperazone, although effective against Borrelia persisters, could not completely eliminate the microcolony form of B. burgdorferi [30] . It was also observed from previous in vivo and in vitro studies that doxycycline was effective in eliminating the spirochetes but not the persisters of Borrelia [7, 16, 17, 30, 31] . However, J. Feng et al. also showed that the three-antibiotic combination (doxycycline, cefoperazone, and daptomycin) was very potent in eliminating the stationary phase rich persisters of Borrelia [30] . In this study, we provided evidence that Stevia A, as an individual agent, was capable of eliminating the spirochetes and the persisters of Borrelia similar to the reported three-drug combination treatment. Our data also showed that the antibiotics in combination on the persisters of Borrelia was indeed consistent with the previous study [30] ; this result further confi rms the effectiveness of Stevia A.
In our previous studies, we characterized the biofi lm form of B. burgdorferi in vitro, and showed that it represents the most antibiotic resistant form [24] . It is also reported that biofi lms attached to a surface are protected from antibiotics or other antimicrobial agents [28, 29] . In this study, we also evaluated the effect of all antimicrobial agents on attached Borrelia biofi lms. Our results showed that Stevia A is very effective, in reducing attached Borrelia biofi lm mass on both plastic and collagen coated surfaces by ~40% (Fig. 4) whereas the individual antibiotics actually induced the size of the biofi lm mass (Fig. 4) .
It was previously reported that certain antibiotics could indeed promote bacterial biofi lm formation [49] . One potential explanation is that cells in biofi lms are capable of protecting themselves from unfavorable antibiotic environment [24, 28] by developing several defensive mechanisms such as poor antibiotic penetration, phenotypic changes of cells forming in the biofi lm, the expression of effl ux pumps, and the presence of persister cells, which resist dying when exposed to antimicrobial agents [28, 29] . Persisters are a subpopulation of highly resistant cells, which are found among the normal cell population, and they are dormant and highly protected [28] . Studies show that small fraction of cells in biofi lms were unaffected after prolonged antibiotic treatment [29, 53] .
The obvious question on how Stevia could affect the highly resistant Borrelia biofi lm warrants further investigation. In a study using a sugar alcohol, it was reported that xylitol acts as an antiplaque agent by disrupting the formation of biofi lms in the oral cavity [54] . In another study, they showed that xylitol affects the production of adhesive polysaccharides of Streptococcus mutans [55] . It was previously shown that sugars prime the uptake of antibiotics in Staphylococcus aureus and Escherichia coli [56] . Based on these previous fi ndings, we hypothesize that Stevia could act as a sugar derivative, which might prime the uptake of the phytochemicals responsible for the antimicrobial effect and, thereby, disrupt the biofi lm structure. In support to our hypothesis, we also showed that the ultrastructure of Stevia A-treated biofi lm has very loose morphology with large shallow pits compared to the compact structure of biofi lms treated with doxycycline, cefoperazone, daptomycin, and the antibiotic combination (Fig. 6: panels ii-vi) .
To further confi rm the effectiveness of Stevia, we performed long-term subculture experiments using the antimicrobial treated, stationary phase predominated with Borrelia persisters by transferring a population of the treated cells into fresh culture medium to observe if viable cells can regrow after a 7-day and a 14-day period in the absence of antimicrobial agent. The natural antimicrobial agent (Stevia A) was shown to be effective with no regrowth of viable cells after a 7-day subculture and with only 10% increase in viable cells after a 14-day subculture. The effects of the three-antibiotic combination, when compared to Stevia A, regrew with 5% and 11% of viable cells as detected using the SYBR Green I/PI method and confi rmed by fl uorescent microscopy (Fig. 3A, and 3B: panels vii, viii, xv, and xvi). We also observed that Borrelia treated with doxycycline and cefoperazone, which did not show any signifi cant effect against the persisters ( Fig. 2A, 2B , and 2C: panels xii and xiii), recovering with only 13% and 6% viable cells after a 7-day subculture (Fig. 3A, and 3C : panels iv and v). One possible explanation for this phenomenon could be that antibiotic sensitivity might have been restored when bacteria are dispersed from a biofi lm during favorable conditions [28] .
Stevia leaf extract is a widely used sugar substitute [39] [40] [41] 57] ; however, recent studies show that one of the major glycosides, stevioside, could have antimicrobial effect against Bacillus cereus, Bacillus subtilis, Klebsiella pneumoniae, and Pseudomonas aeruginosa [42] . These antimicrobial studies used a high concentration of purifi ed stevioside, and in our study, we achieved similar antimicrobial effect against Borrelia by using a lower concentration of the whole leaf extract. Our data with purifi ed Stevioside did not show any signifi cant antimicrobial effect on Borrelia spirochetes and persisters compared to the whole leaf extracts of Stevia (Fig. 1) . This fi nding suggests that other components within the Stevia whole leaf extract could have antimicrobial activity against B. burgdorferi, which are yet to be identifi ed in future studies. In a good agreement with our fi ndings, Stevia leaf extract has also demonstrated antimicrobial activity against pathogens such as E. coli, S. aureus, Vibrio mimicus, Salmonella typhimurium, S. mutans, Bacillus subtilis, Shigella dysenteriae, and Vibrio cholera [38] [39] [40] [41] [42] . The next question is whether Stevia could be safely used as a therapeutic agent. Toxicological studies have shown that Stevia does not have mutagenic, teratogenic, or carcinogenic effects [57] , and recent studies demonstrated its safety at high dietary intake levels [57] [58] [59] . In a study examining the mutagenicity of Stevioside and Steviol, it was noted that Stevioside at 10 mg/ml did not induce any mutation in S. typhimurium [60] . Apart from these studies, there are two important clinical studies based on the glycoproteins present in Stevia. In a randomized, doubleblinded study on Chinese men and women experiencing mild hyper tension, it was reported that the glycoprotein stevioside decreased the systolic and diastolic blood pressure and also improved quality of life without causing any adverse effects compared to the placebo [44] . In another study, the acute effects of stevioside in type 2 diabetic patients were analyzed [45] . Compared to the control group, stevioside reduces postprandial blood glucose levels in type 2 diabetic patients [45] . It was noted that both these studies used an encapsulated powdered form of stevioside and whole leaf extract that had been taken orally [44, 45] . It was also observed that one of the clinical studies used a whole leaf preparation, which contained 91% stevioside, 4% rebaudioside A, and 5% of other derivatives of stevioside [45] . The outcome from these clinical studies demonstrates that the patients did not encounter any adverse effects from the use of stevioside [44, 45] . Although the safeness of Stevia is widely studied, more in vivo studies are warranted before Stevia could be used as an antimicrobial agent for any infectious diseases.
Our future goal is to further investigate the individual components of whole leaf Stevia extract against B. burgdorferi and to identify the most effective component responsible for its signifi cant antimicrobial effect. In conclusion, the overall antimicrobial effectiveness of Stevia A extract on the different morphological forms of B. burgdorferi was comparable to the combination of certain antibiotics. Although the results of this preliminary study cannot be extrapolated directly to clinical practice, further follow-up studies are necessary which can address the safeness of Stevia and to further identify the most effective component(s) against Borrelia.
